Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
53.67
+0.97 (1.83%)
Nov 21, 2024, 11:19 AM EST - Market open
Exact Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,692 | 2,500 | 2,084 | 1,767 | 1,491 | 876.29 | Upgrade
|
| Revenue Growth (YoY) | 11.91% | 19.93% | 17.95% | 18.49% | 70.19% | 92.82% | Upgrade
|
| Cost of Revenue | 727.88 | 654.25 | 574.39 | 458.76 | 354.32 | 216.72 | Upgrade
|
| Gross Profit | 1,964 | 1,846 | 1,510 | 1,308 | 1,137 | 659.58 | Upgrade
|
| Selling, General & Admin | 1,653 | 1,638 | 1,640 | 1,538 | 1,071 | 737.63 | Upgrade
|
| Research & Development | 446.52 | 425.88 | 393.42 | 385.65 | 554.05 | 139.69 | Upgrade
|
| Other Operating Expenses | -2.03 | -2.03 | - | - | - | - | Upgrade
|
| Operating Expenses | 2,192 | 2,154 | 2,131 | 2,019 | 1,719 | 893.36 | Upgrade
|
| Operating Income | -227.22 | -308.84 | -620.92 | -710.57 | -581.7 | -233.78 | Upgrade
|
| Interest Expense | -25.3 | -19.45 | -19.63 | -18.61 | -67.94 | -199.19 | Upgrade
|
| Interest & Investment Income | 54.93 | 32.71 | - | 31.78 | 6.57 | 26.53 | Upgrade
|
| EBT Excluding Unusual Items | -197.6 | -295.57 | -640.55 | -697.4 | -643.06 | -406.44 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -117.7 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -19.43 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -13.24 | - | - | - | Upgrade
|
| Asset Writedown | -31.3 | -0.62 | -15.97 | -20.21 | -209.67 | - | Upgrade
|
| Other Unusual Items | 18.32 | 94.44 | 56.62 | -7.2 | 23.67 | - | Upgrade
|
| Pretax Income | -210.57 | -201.75 | -632.57 | -842.51 | -829.06 | -406.44 | Upgrade
|
| Income Tax Expense | 3.47 | 2.4 | -9.06 | -246.88 | -5.46 | -193.35 | Upgrade
|
| Net Income | -214.04 | -204.15 | -623.51 | -595.63 | -823.61 | -213.09 | Upgrade
|
| Net Income to Common | -214.04 | -204.15 | -623.51 | -595.63 | -823.61 | -213.09 | Upgrade
|
| Shares Outstanding (Basic) | 183 | 180 | 176 | 171 | 151 | 131 | Upgrade
|
| Shares Outstanding (Diluted) | 183 | 180 | 176 | 171 | 151 | 131 | Upgrade
|
| Shares Change (YoY) | 2.17% | 2.15% | 2.92% | 13.37% | 15.15% | 7.41% | Upgrade
|
| EPS (Basic) | -1.17 | -1.13 | -3.54 | -3.48 | -5.45 | -1.62 | Upgrade
|
| EPS (Diluted) | -1.17 | -1.13 | -3.54 | -3.48 | -5.45 | -1.62 | Upgrade
|
| Free Cash Flow | 98.43 | 31.93 | -438.02 | -238 | 71.4 | -284.31 | Upgrade
|
| Free Cash Flow Per Share | 0.54 | 0.18 | -2.48 | -1.39 | 0.47 | -2.17 | Upgrade
|
| Gross Margin | 72.96% | 73.83% | 72.44% | 74.04% | 76.24% | 75.27% | Upgrade
|
| Operating Margin | -8.44% | -12.35% | -29.79% | -40.21% | -39.00% | -26.68% | Upgrade
|
| Profit Margin | -7.95% | -8.17% | -29.91% | -33.71% | -55.22% | -24.32% | Upgrade
|
| Free Cash Flow Margin | 3.66% | 1.28% | -21.02% | -13.47% | 4.79% | -32.44% | Upgrade
|
| EBITDA | -11.34 | -102.23 | -423.36 | -530.22 | -418.33 | -183.54 | Upgrade
|
| EBITDA Margin | -0.42% | -4.09% | -20.31% | -30.01% | -28.05% | -20.94% | Upgrade
|
| D&A For EBITDA | 215.88 | 206.61 | 197.56 | 180.35 | 163.36 | 50.25 | Upgrade
|
| EBIT | -227.22 | -308.84 | -620.92 | -710.57 | -581.7 | -233.78 | Upgrade
|
| EBIT Margin | -8.44% | -12.35% | -29.79% | -40.21% | -39.00% | -26.68% | Upgrade
|
| Advertising Expenses | - | 137.9 | 170.3 | 144 | 97.6 | 90.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.